The effectiveness of a single respiratory syncytial virus (RSV) vaccine dose declined among older adults, potentially suggesting the need for booster shots among this demographic. That is according to ...
On Wednesday 26 November 2025, nearly 150 students from five Luxembourg secondary schools took part in a meeting... }} ...
An infant immunization for respiratory syncytial virus (RSV) is now available across Canada, but it still has to be paid for ...
RSV infection in adults ≥65 is linked to rare but elevated Guillain-Barré syndrome risk, particularly in those aged ≥75 years ...
Please provide your email address to receive an email when new articles are posted on . Respiratory syncytial virus (RSV) is a highly contagious RNA virus that infects nearly all children by age 2 and ...
Some hospitals are reporting an uptick in respiratory syncytial virus hospitalizations in recent days, though national data — delayed by the federal shutdown — has yet to offer a clear picture.
Veterans aged 60 years and older who received a single dose of the respiratory syncytial virus (RSV) prefusion F3 (RSVPreF3) or RSV prefusion F (RSVpreF) vaccine remained protecte ...
Background Respiratory syncytial virus (RSV) is an important cause of acute lower respiratory infections (ALRI) among under-5 ...
Vaccination during pregnancy shows about 70% to 80% effectiveness in protecting newborns through antibody transfer. For adults over 60, vaccines demonstrate roughly 75% real-world effectiveness ...
Rythu Swarajya Vedika (RSV) has appealed to farmers across Telangana who suffered severe crop damage during Cyclone Montha to immediately check the crop-loss enumeration lists displayed in their Gram ...
The CDC monitors respiratory illness activity by looking at a range of diagnoses from emergency department (ED) visits, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback